Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Management of Shock

Introduction to Shock Management

  • The management of shock requires a standardized approach focused on rapid diagnosis, early intervention, ongoing hemodynamic assessment, and multidisciplinary longitudinal care to reduce mortality rates that currently exceed 40% 1, 2, 3

Clinical Criteria and Hemodynamic Assessment

  • Clinical criteria for shock diagnosis include systolic blood pressure <90 mmHg for 30 minutes or requiring inotropes/vasopressors to maintain SBP >90 mmHg, evidence of end-organ hypoperfusion, and lactate >2 mmol/L 4, 5
  • Hemodynamic criteria include cardiac index <1.8 L/min/m² without vasopressors/inotropes and cardiac power output <0.6 W 4, 5

Management of Cardiogenic Shock

  • Early revascularization for acute myocardial infarction with cardiogenic shock 1, 2
  • Consider mechanical circulatory support (MCS) in refractory shock based on cardiac index <2.2 L/min/m², cardiac power output <0.6 W, and lactate elevation despite initial therapy 4, 5, 8

Management of Septic Shock

  • Norepinephrine is the preferred vasopressor in septic shock 7
  • Consider vasopressin or angiotensin II for their norepinephrine-sparing effects 7

Inotropic and Vasopressor Support

  • Dobutamine remains the first-line inotropic therapy when myocardial function is depressed 7
  • For patients with left ventricular-dominant cardiogenic shock and normotensive hypoperfusion, pure vasodilators like nitroprusside may improve cardiac output by reducing afterload, and milrinone and dobutamine can be effective for high-afterload LV failure 5, 6

Advanced Monitoring and Care

  • Early invasive hemodynamic assessment using pulmonary artery catheter (PAC) to guide therapy 4, 5
  • Implement a multidisciplinary shock team approach with standardized protocols 1, 2, 3
  • For optimal outcomes, consider transfer to dedicated Level 1 shock centers with full spectrum capabilities 9
  • Ongoing hemodynamic assessment and titration of therapies to the minimal efficacious dose 7

Special Considerations for Right Ventricular Failure

  • Minimize intrathoracic positive pressure ventilation, correct acidosis, and improve oxygenation in RV failure 5, 6